Peptide research
Browse curated peptide and peptide-therapy topics on Synapse. Each page combines a ranked literature feed, active researchers, and AI-enriched paper metadata drawn from our corpus of 600,000+ publications.
Synapse surfaces peer-reviewed research and researcher networks for informational purposes only. This page does not provide medical advice, dosing guidance, or treatment recommendations.
Peptide directory
GLP-1 receptor agonists
GLP-1 receptor agonists in cardiometabolic and obesity research, including cardiovascular outcome trials and mechanistic studies.
Also known as: GLP-1 RA, glucagon-like peptide-1, incretin-based therapy
Semaglutide
Peer-reviewed research on semaglutide across obesity, type 2 diabetes, and cardiovascular outcome trials.
Also known as: Ozempic, Wegovy, Rybelsus
Tirzepatide
Research on tirzepatide, a dual GIP/GLP-1 receptor agonist, including SURPASS, SURMOUNT, and cardiovascular-focused substudies.
Also known as: Mounjaro, Zepbound, dual GIP/GLP-1
Retatrutide
Early-phase and translational research on retatrutide, a GLP-1/GIP/glucagon tri-agonist in development for obesity and metabolic disease.
Also known as: LY3437943, triple incretin
BPC-157
Preclinical and limited clinical literature on BPC-157, a synthetic pentadecapeptide studied in wound healing and GI models.
Also known as: Body Protection Compound 157, pentadecapeptide BPC-157
Thymosin beta-4
Research on thymosin beta-4, an actin-binding peptide studied in tissue repair, cardiac injury models, and regenerative biology.
Also known as: Tβ4, TB-500, thymosin β4
CJC-1295
Studies on CJC-1295, a long-acting GHRH analog, in growth hormone axis and body-composition research contexts.
Also known as: CJC1295, growth hormone releasing hormone analog
Ipamorelin
Research on ipamorelin, a selective growth hormone secretagogue peptide, in pituitary signaling and metabolic studies.
Also known as: IPAM, growth hormone secretagogue
Tesamorelin
Clinical and translational research on tesamorelin, an FDA-approved GHRH analog for HIV-associated lipodystrophy, and related metabolic studies.
Also known as: Egrifta, GHRH analog HIV lipodystrophy
Sermorelin
Literature on sermorelin, a GHRH(1-29) analog used in growth hormone deficiency diagnostics and research settings.
Also known as: GHRH 1-29, growth hormone releasing factor 1-29
Bremelanotide
Research on bremelanotide (PT-141), a melanocortin receptor agonist peptide studied for hypoactive sexual desire disorder.
Also known as: PT-141, Vyleesi
Oxytocin
Peer-reviewed research on oxytocin in social neuroscience, obstetrics, and intranasal peptide administration studies.
Also known as: OT, pitocin research contexts
Frequently asked questions
What peptide research does Synapse cover?
We maintain 12 curated topics spanning approved incretin therapies, investigational metabolic peptides, and research peptides studied in preclinical models.
How are papers ranked on each peptide page?
Feeds use indexed MeSH descriptor matching for fast, crawler-safe retrieval. Papers include methodology tags, clinical evidence, graphical abstracts when available, and citation context.